CAS: 1217439-06-9 - N-(4,5-Dihydro-1H-imidazol-2-yl)-5-methyl-6-quinolinamine
Formula:C13H14N4
InChI:InChI=1S/C13H14N4/c1-9-10-3-2-6-14-12(10)5-4-11(9)17-13-15-7-8-16-13/h2-6H,7-8H2,1H3,(H2,15,16,17)
InChI key:InChIKey=FCRZSJQZPZTROM-UHFFFAOYSA-N
SMILES:N=1C=CC=C2C1C=CC(NC3=NCCN3)=C2C
- Synonyms:
- N-(4,5-Dihydro-1H-imidazol-2-yl)-5-methyl-6-quinolinamine
- 6-Quinolinamine, N-(4,5-dihydro-1H-imidazol-2-yl)-5-methyl-
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Bempedoic Acid Impurity 5 REF: 4Z-B-168009CAS: 1217439-06-9 | - - - | To inquire | Thu 02 Jan 25 |
| Brimonidine Tartrate Impurity 3 REF: 4Z-B-168CAS: 1217439-06-9 | - - - | To inquire | Wed 08 Jan 25 |
| Bempedoic Acid Impurity 10 REF: 4Z-B-168015CAS: 1217439-06-9 | - - - | To inquire | Wed 08 Jan 25 |
 | N-(4,5-Dihydro-1H-imidazol-2-yl)-5-methyl-6-quinolinamine REF: 3D-SYB43906CAS: 1217439-06-9 | Min. 95% | - - - | Discontinued product |
Ref: 4Z-B-168009
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 2 Jan 2025
Ref: 4Z-B-168
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 8 Jan 2025
Ref: 4Z-B-168015
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 8 Jan 2025
N-(4,5-Dihydro-1H-imidazol-2-yl)-5-methyl-6-quinolinamine
CAS:1217439-06-9
Please enquire for more information about N-(4,5-Dihydro-1H-imidazol-2-yl)-5-methyl-6-quinolinamine including the price, delivery time and more detailed …
Formula:
C13H14N4
Purity:
Min. 95%
Molecular weight:
226.28 g/mol
Ref: 3D-SYB43906
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information | |
| 250mg | Discontinued | Request information |
